The investigational PAM inhibitor extends progression-free survival from 5 to 7 months in patients with advanced, PIK3CA wild ...

Using single-cell transcriptomic analysis, the team discovered that elevated Selp triggers a pro-inflammatory state within ageing HSCs. This shift activates major cellular pathways linked to ageing ...

Accepted Presentations Showcase First-in-Human Development, Manufacturing Innovation, and Predictive Biomarkers for Deciparticle™ Everolimus (Sapu003) AGOURA HILLS, Calif., Oct. 23, 2025 (GLOBE ...

(A) The Venn diagram showed the distribution of the DEGs between circFKBP8(5S,6) and cFKBP8-regulated genes. (B, C) DEGs involved in the neuroactive ligand-receptor ...

Amid steady Q3 growth, Roche's giredestrant-Afinitor combo extended survival in advanced ER-positive, HER2-negative early breast cancer.